Form D · Biotechnology
ZSX Medical, LLC
Philadelphia, PA · CIK 0001668486
Offering snapshot reported Jan 23, 2020 · SEC filing
- Reported sold
- $235K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2020 | Initial | $235,200 | No comparison | 3 | SEC filing |
| Jul 20, 2018 | Initial | $239,155 | No comparison | 6 | SEC filing |
| Feb 9, 2017 | Amendment | $1,576,671 | $903,121vs Mar 3, 2016 | 22 | SEC filing |
| Mar 3, 2016 | Initial | $673,550 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-358799
Source: Form D, filed Jan 23, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director |
| Louis Berardi | Director |
| Rugart Eric | Director, Executive |
| Daniel Mazzucco | Director, Executive |
| Eric Rugart | Director, Executive |
| Gary Zebrowski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3401 Grays Ferry Ave Building 176, Pennovation Center
Philadelphia, PA, 19146
Philadelphia, PA, 19146